This inventor holds 1 USPTO granted patent. Top assignee: Natco Pharma Limited. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Swapna Kondaveeti: Innovator in Pharmaceutical Chemistry
Introduction
Swapna Kondaveeti is a prominent inventor based in Hyderabad, Telangana, India. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds. Her work is characterized by a commitment to innovation and excellence.
Latest Patents
Swapna holds a patent for the "Process for the preparation of ribociclib succinate and its novel crystalline forms thereof." This invention relates to an improved process for synthesizing the compound 7-cyclopentyl-N,N-dimethyl-2-{[5-(piperazin-1-yl)pyridin-2-yl]amino}-7H-pyrrolo[2,3-d]pyrimidine-6-carboxamide succinate (1/1), represented by the structural formula of formula-1a. This patent highlights her expertise in creating innovative pharmaceutical solutions.
Career Highlights
Swapna is currently employed at Natco Pharma Limited, where she continues to advance her research and development efforts. Her work at Natco Pharma has positioned her as a key player in the pharmaceutical industry, contributing to the development of important therapeutic agents.
Collaborations
Throughout her career, Swapna has collaborated with talented professionals, including Arunkumar Thiriveedhi and Sathish Thumati. These collaborations have fostered a dynamic environment for innovation and have led to significant advancements in their respective fields.
Conclusion
Swapna Kondaveeti is a remarkable inventor whose contributions to pharmaceutical chemistry are noteworthy. Her patent for ribociclib succinate exemplifies her innovative spirit and dedication to improving healthcare solutions. Her ongoing work at Natco Pharma Limited continues to inspire future advancements in the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
